vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与CORCEPT THERAPEUTICS INC（CORT）财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是CORCEPT THERAPEUTICS INC的2.0倍（$396.1M vs $202.1M），CORCEPT THERAPEUTICS INC净利率更高（12.0% vs 4.7%，领先7.3%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs 11.1%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $-59.8M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 4.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
CMP vs CORT — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $202.1M |
| 净利润 | $18.6M | $24.3M |
| 毛利率 | 16.0% | 98.7% |
| 营业利润率 | 9.2% | 2.2% |
| 净利率 | 4.7% | 12.0% |
| 营收同比 | 28.9% | 11.1% |
| 净利润同比 | 178.8% | -21.0% |
| 每股收益（稀释后） | $0.43 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $396.1M | $202.1M | ||
| Q3 25 | $227.5M | $207.6M | ||
| Q2 25 | $214.6M | $194.4M | ||
| Q1 25 | $494.6M | $157.2M | ||
| Q4 24 | $307.2M | $181.9M | ||
| Q3 24 | $208.8M | $182.5M | ||
| Q2 24 | $202.9M | $163.8M | ||
| Q1 24 | $364.0M | $146.8M |
| Q4 25 | $18.6M | $24.3M | ||
| Q3 25 | $-7.2M | $19.7M | ||
| Q2 25 | $-17.0M | $35.1M | ||
| Q1 25 | $-32.0M | $20.5M | ||
| Q4 24 | $-23.6M | $30.7M | ||
| Q3 24 | $-48.3M | $47.2M | ||
| Q2 24 | $-43.6M | $35.5M | ||
| Q1 24 | $-38.9M | $27.8M |
| Q4 25 | 16.0% | 98.7% | ||
| Q3 25 | 16.9% | 97.8% | ||
| Q2 25 | 19.2% | 98.2% | ||
| Q1 25 | 15.5% | 98.5% | ||
| Q4 24 | 11.2% | 98.4% | ||
| Q3 24 | 9.3% | 98.4% | ||
| Q2 24 | 16.1% | 98.5% | ||
| Q1 24 | 19.7% | 98.3% |
| Q4 25 | 9.2% | 2.2% | ||
| Q3 25 | 5.3% | 4.9% | ||
| Q2 25 | 7.4% | 13.7% | ||
| Q1 25 | -0.6% | 2.2% | ||
| Q4 24 | 0.2% | 13.9% | ||
| Q3 24 | -14.3% | 25.5% | ||
| Q2 24 | 2.9% | 21.7% | ||
| Q1 24 | -10.8% | 20.1% |
| Q4 25 | 4.7% | 12.0% | ||
| Q3 25 | -3.2% | 9.5% | ||
| Q2 25 | -7.9% | 18.1% | ||
| Q1 25 | -6.5% | 13.1% | ||
| Q4 24 | -7.7% | 16.9% | ||
| Q3 24 | -23.1% | 25.9% | ||
| Q2 24 | -21.5% | 21.7% | ||
| Q1 24 | -10.7% | 18.9% |
| Q4 25 | $0.43 | $0.20 | ||
| Q3 25 | — | $0.16 | ||
| Q2 25 | $-0.41 | $0.29 | ||
| Q1 25 | $-0.77 | $0.17 | ||
| Q4 24 | $-0.57 | $0.25 | ||
| Q3 24 | $-1.17 | $0.41 | ||
| Q2 24 | $-1.05 | $0.32 | ||
| Q1 24 | $-0.94 | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $372.2M |
| 总债务越低越好 | $890.0M | — |
| 股东权益账面价值 | $260.5M | $647.8M |
| 总资产 | $1.5B | $836.7M |
| 负债/权益比越低杠杆越低 | 3.42× | — |
8季度趋势，按日历期对齐
| Q4 25 | $46.7M | $372.2M | ||
| Q3 25 | $59.7M | $421.7M | ||
| Q2 25 | $79.4M | $342.2M | ||
| Q1 25 | $49.5M | $322.8M | ||
| Q4 24 | $45.8M | $383.3M | ||
| Q3 24 | $20.2M | $380.3M | ||
| Q2 24 | $12.8M | $473.2M | ||
| Q1 24 | $38.3M | $410.8M |
| Q4 25 | $890.0M | — | ||
| Q3 25 | $839.8M | — | ||
| Q2 25 | $833.4M | — | ||
| Q1 25 | $807.6M | — | ||
| Q4 24 | $974.4M | — | ||
| Q3 24 | $921.2M | — | ||
| Q2 24 | $875.1M | — | ||
| Q1 24 | $877.2M | — |
| Q4 25 | $260.5M | $647.8M | ||
| Q3 25 | $234.1M | $631.9M | ||
| Q2 25 | $249.8M | $635.8M | ||
| Q1 25 | $236.5M | $683.3M | ||
| Q4 24 | $263.0M | $679.6M | ||
| Q3 24 | $316.6M | $638.8M | ||
| Q2 24 | $352.1M | $596.2M | ||
| Q1 24 | $400.4M | $547.9M |
| Q4 25 | $1.5B | $836.7M | ||
| Q3 25 | $1.5B | $823.6M | ||
| Q2 25 | $1.5B | $801.7M | ||
| Q1 25 | $1.5B | $846.5M | ||
| Q4 24 | $1.7B | $840.6M | ||
| Q3 24 | $1.6B | $784.3M | ||
| Q2 24 | $1.6B | $714.6M | ||
| Q1 24 | $1.7B | $655.9M |
| Q4 25 | 3.42× | — | ||
| Q3 25 | 3.59× | — | ||
| Q2 25 | 3.34× | — | ||
| Q1 25 | 3.41× | — | ||
| Q4 24 | 3.70× | — | ||
| Q3 24 | 2.91× | — | ||
| Q2 24 | 2.49× | — | ||
| Q1 24 | 2.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $38.4M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $38.4M |
| 自由现金流率自由现金流/营收 | -15.1% | 19.0% |
| 资本支出强度资本支出/营收 | 5.8% | 0.0% |
| 现金转化率经营现金流/净利润 | -1.99× | 1.58× |
| 过去12个月自由现金流最近4个季度 | $94.1M | — |
8季度趋势，按日历期对齐
| Q4 25 | $-37.0M | $38.4M | ||
| Q3 25 | $-6.9M | $54.5M | ||
| Q2 25 | $21.8M | $43.9M | ||
| Q1 25 | $186.9M | $5.1M | ||
| Q4 24 | $-4.1M | $59.3M | ||
| Q3 24 | $-12.7M | $73.8M | ||
| Q2 24 | $-6.8M | $41.2M | ||
| Q1 24 | $86.2M | $23.8M |
| Q4 25 | $-59.8M | $38.4M | ||
| Q3 25 | $-22.8M | — | ||
| Q2 25 | $3.8M | $43.9M | ||
| Q1 25 | $172.9M | $5.0M | ||
| Q4 24 | $-25.9M | $59.2M | ||
| Q3 24 | $-33.6M | $72.2M | ||
| Q2 24 | $-21.5M | $40.8M | ||
| Q1 24 | $56.2M | — |
| Q4 25 | -15.1% | 19.0% | ||
| Q3 25 | -10.0% | — | ||
| Q2 25 | 1.8% | 22.6% | ||
| Q1 25 | 35.0% | 3.2% | ||
| Q4 24 | -8.4% | 32.5% | ||
| Q3 24 | -16.1% | 39.5% | ||
| Q2 24 | -10.6% | 24.9% | ||
| Q1 24 | 15.4% | — |
| Q4 25 | 5.8% | 0.0% | ||
| Q3 25 | 7.0% | 0.0% | ||
| Q2 25 | 8.4% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 7.1% | 0.1% | ||
| Q3 24 | 10.0% | 0.9% | ||
| Q2 24 | 7.2% | 0.3% | ||
| Q1 24 | 8.2% | 0.0% |
| Q4 25 | -1.99× | 1.58× | ||
| Q3 25 | — | 2.77× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | — | 1.56× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
CORT
暂无分部数据
